Breaking News, Collaborations & Alliances

RoslinCT, Lykan Bioscience Granted MIA License for cGMP Manufacturing Facilities

cGMP facility designed and purpose-built specifically to accommodate cell therapy manufacturing processes.

RoslinCT and Lykan Bioscience, companies involved in contract development and manufacturing for cell therapies, have been granted a Manufacturer’s Authorization License (MIA) for commercial manufacturing of cell therapy products from the Medicines and Healthcare products Regulatory Agency (MHRA), following a successful inspection at their Edinburgh, UK facility. Completed in late 2021, RoslinCT’s newest 1,600 square-meter state-of-the-art facility, located in Edinburgh’s Bio...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters